Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in HUMA — Humacyte, Inc.

CIK 1214717 BOSTON, MA
Back to HUMA Full portfolio

Position in HUMA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,704,475
-$515,996 QoQ
Shares Held
2,185,225
-40.3% QoQ
Ownership
0.787%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 163 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HUMA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. HUMA ranks #296 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in HUMA

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,704,475 2,185,225
2026-03-31 $2,220,471 3,658,108
2025-12-31 $3,575,338 3,720,436
2025-09-30 $5,387,415 3,096,216
2025-06-30 $6,162,381 2,948,508
2025-03-31 $3,768,673 2,210,366
2024-12-31 $10,782,420 2,135,133
2024-09-30 $11,098,785 2,040,218
2024-06-30 $8,933,270 1,861,098
2024-03-31 $4,200,173 1,350,538
2023-12-31 $3,764,917 1,325,675
2023-09-30 $3,601,201 1,229,079
2023-06-30 $3,151,625 1,101,967
2023-03-31 $3,256,652 1,053,933
2022-12-31 $1,846,653 875,191
2022-09-30 $2,222,658 681,797
2022-06-30 $2,497,370 777,997
2022-03-31 $4,234,510 599,789
2021-12-31 $4,381,262 604,312
2021-09-30 $359,120 30,932